Latest News and Press Releases
Want to stay updated on the latest news?
-
OmniCath™ II Patent Filing Showcases Product Effectiveness Houston, TX, Oct. 16, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma (OTC: SOAN), a leading pharmaceutical research and...
-
HOUSTON, TX, Oct. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – AngioSoma (OTC: SOAN), a leading biotechnology company, announces today the availability of the anticipated new and improved version...
-
Houston, TX., July 11, 2018 (GLOBE NEWSWIRE) -- AngioSoma (OTC: SOAN) today launched a new corporate logo and website, marking the most dramatic change in its visual identity since 2016. Taking a...
-
HOUSTON, TX, June 25, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (OTC: SOAN) is in discussions to engage a respected pharmaceutical regulatory advisory firm to help it navigate the Food and Drug...
-
HOUSTON, TX, June 18, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (SOAN) is excited to announce that we have identified a regulatory firm who can assist taking our patented flagship drug, Liprostin™,...
-
HOUSTON, TX, May 14, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (OTC: SOAN) is excited to announce that the U.S. Patent Office has agreed to grant our patent application for our flagship...